JSC Valenta Pharmaceuticals is in TOP-3 of Russian pharmaceutical producers. The company provides more than 30 medicines for efficient treatment in the following therapeutic areas: psychoneurology, urology, gastroenterology, and general practice. The key Company’s brands are Ingavirin, Grammidin, Trimedat, Phenotropil, Phenazepam, Pantocalcin, etc. There are also new medicines in the R&D pipeline and registration process. Valenta has got its own production spot in Schelkovo (Moscow region). This allows implementing complicated manufacturing projects. Also, the Company is building a new plant to be opened in 2016 in the same area. All equipment for the new plant is being manufactured in Europe using state-of-the-art technologies. It will make this enterprise one of the most advanced production spots in Russian pharmaceutical market. The new plant will operate in strict accordance with GMP standards. Being a socially-responsible company, Valenta stands for responsible healthcare solutions for patients and doctors by providing them with great medicines. Company employs over 1300 people all over Russia. We are working as one team to develop Russian healthcare system and innovative medical science. All the employees are offered to have an attractive compensation package that includes competitive salary, annual bonuses, corporate transport, mobiles’ coverage, medical insurance and etc. Also, there are different educational and motivation programs for people development at all corporate levels. High expansion rate of our business gives our employees great opportunities for dynamic career growth. Our corporate culture is based on the values of respect, openness and transparency. We invite you to become a member of our team!